Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines

Heedo Park; Mee Sook Park; Jong Hyeon Seok; Jaehwan You; Jineui Kim; Jeonghun Kim; Man-Seong Park

doi:10.1007/s12275-022-1598-x

Articles

Page Path: HOME > J. Microbiol > Volume 60(3); 2022 > Article

Review
Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines: Heedo Park , Mee Sook Park , Jong Hyeon Seok , Jaehwan You , Jineui Kim , Jeonghun Kim , Man-Seong Park; Journal of Microbiology 2022;60(3):308-320.
DOI: https://doi.org/10.1007/s12275-022-1598-x
Published online: March 2, 2022

Department of Microbiology, Institute for Viral Diseases, Chung Mong-Koo Vaccine Innovation Center, College of Medicine, Korea University, Seoul 02841, Republic of KoreaDepartment of Microbiology, Institute for Viral Diseases, Chung Mong-Koo Vaccine Innovation Center, College of Medicine, Korea University, Seoul 02841, Republic of Korea

Corresponding author: Man-Seong Park ,

Received: 16 November 2021 • Revised: 24 December 2021 • Accepted: 31 December 2021

prev next

56 Views
0 Download
5 Web of Science
6 Crossref
6 Scopus

Full Article

Abstract

The three types of approved coronavirus disease 2019 (COVID- 19) vaccines that have been emergency-use listed (EUL) by the World Health Organization are mRNA vaccines, adenovirus- vectored vaccines, and inactivated vaccines. Canonical vaccine developments usually take years or decades to be completed to commercialization; however, the EUL vaccines being used in the current situation comprise several COVID- 19 vaccine candidates applied in studies and clinical settings across the world. The extraordinary circumstances of the COVID-19 pandemic have necessitated the emergency authorization of these EUL vaccines, which have been rapidly developed. Although the benefits of the EUL vaccines outweigh their adverse effects, there have been reports of rare but fatal cases directly associated with COVID-19 vaccinations. Thus, a reassessment of the immunological rationale underlying EUL vaccines in relation to COVID-19 caused by SARSCOV- 2 virus infection is now required. In this review, we discuss the manifestations of COVID-19, immunologically projected effects of EUL vaccines, reported immune responses, informed issues related to COVID-19 vaccination, and the potential strategies for future vaccine use against antigenic variants.

Keywords: Cryptococcus;DNA N-glycosylase;DNA damage;DNA mutation

Figure & Data

References

Citations

Citations to this article as recorded by

Single intranasal immunization with attenuated Wuhan-like SARS-CoV-2 provides highly effective cross-protection against Delta and Omicron variants of concern
Evgeny B. Faizuloev, Anastasiia V. Gracheva, Ekaterina R. Korchevaya, Yulia I. Ammour, Daria I. Smirnova, Darya M. Khokhlova, Andrey O. Drokov, Andrey A. Pankratov, Galina V. Trunova, Varvara A. Khokhlova, Maria S. Vorontsova, Irina A. Leneva, Oksana A. S
Journal of microbiology, epidemiology and immunobiology.2024; 101(1): 36. CrossRef
Real-time infectious disease endurance indicator system for scientific decisions using machine learning and rapid data processing
Shivendra Dubey, Dinesh Kumar Verma, Mahesh Kumar
PeerJ Computer Science.2024; 10: e2062. CrossRef
A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients
Sikai Chen, Wenxin Wei, Fengyu Huang, Jing Wang, Xingyu Li, Zhixin Geng, Feng Gao, Taiwei Dong, Peifeng Wei, Xinbo Yang, Feng Miao
Human Vaccines & Immunotherapeutics.2023;[Epub] CrossRef
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
Vaccines.2023; 11(3): 539. CrossRef
Immunity after COVID-19 Recovery and Vaccination: Similarities and Differences
Dorota Kamińska, Dominika Dęborska-Materkowska, Katarzyna Kościelska-Kasprzak, Oktawia Mazanowska, Agata Remiorz, Paweł Poznański, Magdalena Durlik, Magdalena Krajewska
Vaccines.2022; 10(7): 1068. CrossRef
Two years of COVID-19 pandemic: where are we now?
Jinjong Myoung
Journal of Microbiology.2022; 60(3): 235. CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Insights into the immune responses of SARS-CoV-2 in relation to COVID-19 vaccines

J. Microbiol. 2022;60(3):308-320. Published online March 2, 2022

DOI: https://doi.org/10.1007/s12275-022-1598-x

Related articles